Tenax Therapeutics annual gross margin
2011
2012
2013
2014
2015
Tenax Therapeutics's gross margin was 0.00% for fiscal 2015.
View full Tenax Therapeutics company overview| Fiscal year | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| 2015 | 2015-04-30 | 0.00% | +65.48 pp |
| 2014 | 2014-04-30 | −65.48% | −69.65 pp |
| 2013 | 2013-04-30 | 4.16% | −9.38 pp |
| 2012 | 2012-04-30 | 13.54% | −86.46 pp |
| 2011 | 2011-04-30 | 100.00% | — |
| Fiscal quarter | Period ended | Gross margin | Change (percentage points) |
|---|---|---|---|
| Q3 2014 | 2014-01-31 | 0.43% | −0.17 pp |
| Q2 2014 | 2013-10-31 | 38.29% | +37.23 pp |
| Q1 2014 | 2013-07-31 | 4.76% | +2.72 pp |
| Q4 2013 | 2013-04-30 | 20.52% | +14.95 pp |
| Q3 2013 | 2013-01-31 | 0.60% | −0.86 pp |
| Q2 2013 | 2012-10-31 | 1.06% | −16.72 pp |
| Q1 2013 | 2012-07-31 | 2.04% | −97.96 pp |
| Q4 2012 | 2012-04-30 | 5.57% | −94.43 pp |
| Q3 2012 | 2012-01-31 | 1.46% | −98.54 pp |
| Q2 2012 | 2011-10-31 | 17.78% | — |
| Q1 2012 | 2011-07-31 | 100.00% | — |
| Q3 2011 | 2011-01-31 | 100.00% | — |
| Q2 2011 | 2010-10-31 | 100.00% | — |
Across the available reported history, Tenax Therapeutics's gross margin increased from −65.48% to 0.00%, a change of +65.48 percentage points. The latest reported quarter, Q3 2014, shows 0.43%.
Gross margin measures the percentage of revenue remaining after the direct costs of producing goods or services. It helps show how efficiently a company turns sales into gross profit before operating expenses.
TickerStat calculates gross margin as SEC-reported gross profit divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Tenax Therapeutics filings at SEC.gov ↗